The Egyptian Journal of Internal Medicine

Table 4 Matrix Gla protein levels in the studied groups at baseline and after 3 months

From: Different vitamin K forms in hemodialysis patients: a simple dietary supplement to battle vascular calcification—randomized controlled trial

	Vitamin k1	Vitamin K2		Placebo		ANOVA
	Mean ±SD	Range	Mean ±SD	Range	Mean ±SD	Range	F	P-value
MGP (ng/l)	328±161.04	40–640	332.25±117.528	80–580	125–40.573	20–200	40.673	<0.001*
3 months MGP (ng/l)	584±437.913	200–2800	2706.25±1513.57	300–6400	175.75±69.831	80–350	89.035	<0.001*
Difference	(− 256±491.193)		(− 2374±1477.808)		(− 50.75±76.507)
P-value	0.002*		<0.001*		<0.001*
% of change	78.05		714.52		40.6

Back to article page